CNR1 and astrocytoma (excluding glioblastoma): Thus a glioma grade II patient (relapse-free survival 38 months) and an astrocytoma grade II (relapse free survival) had lower levels of CB1, whereas most of glioblastoma IV patients, with recurrence of the tumor within 9 months from surgery, had high levels of CB1 (Supplementary Table 1).